The Commensal Microbiota and Viral Infection: A Comprehensive Review

Na Li, Wen-Tao Ma, Ming Pang, Qin-Lei Fan, Jin-Lian Hua, Na Li, Wen-Tao Ma, Ming Pang, Qin-Lei Fan, Jin-Lian Hua

Abstract

The human body is inhabited by a diverse microbial community that is collectively coined as commensal microbiota. Recent research has greatly advanced our understanding of how the commensal microbiota affects host health. Among the various kinds of pathogenic infections of the host, viral infections constitute one of the most serious public health problems worldwide. During the infection process, viruses may have substantial and intimate interactions with the commensal microbiota. A plethora of evidence suggests that the commensal microbiota regulates and is in turn regulated by invading viruses through diverse mechanisms, thereby having stimulatory or suppressive roles in viral infections. Furthermore, the integrity of the commensal microbiota can be disturbed by invading viruses, causing dysbiosis in the host and further influencing virus infectivity. In the present article, we discuss current insights into the regulation of viral infection by the commensal microbiota. We also draw attention to the disruption of microbiota homeostasis by several viruses.

Keywords: antibiotics; antiviral immunity; commensal microbiota; germ-free; virus; virus infectivity.

Figures

Figure 1
Figure 1
Mechanisms underlying the suppression of influenza virus infection by the commensal microbiota. During the influenza virus infection, organisms of the commensal microbiota, as well as their components (i.e., various TLR ligands) or metabolites (i.e., desaminotyrosine) activate the inflammasome, resulting in IL-1β and IL-18 production. The production of these two cytokines induces the migration of dendritic cells from the lung to the draining lymph nodes, where they act as antigen-presenting cells to prime virus-specific B cells, CD4+ T cells, CD8+ T cells, and macrophages. In addition, dendritic cells also secrete type I and type II interferons to stimulate the activation of T cells or macrophages. As a result, these effector cells secrete virus-specific antibodies or inflammatory cytokines or exert direct virus-killing effects to suppress the infection process of the influenza virus.
Figure 2
Figure 2
Mechanisms underlying the suppression of vaccinia virus infection by the commensal microbiota. During the vaccinia virus infection, the commensal microbiota primes virus-specific CD8+ T cells to secrete large amounts of IFN-γ, which critically mediates the corresponding antiviral immunity. In addition, during vaccinia virus infections, the activation of TLR2 by bacterial products is essential for recruiting mast cells to sites of viral infection. These mast cells also contribute to suppressing the viral infection by secreting an antiviral cathelicidin.

References

    1. Proctor DM, Relman DA. The landscape ecology and microbiota of the human nose, mouth, and throat. Cell Host Microbe. (2017) 21:421–32. 10.1016/j.chom.2017.03.011
    1. Gimblet C, Meisel JS, Loesche MA, Cole SD, Horwinski J, Novais FO, et al. . Cutaneous leishmaniasis induces a transmissible dysbiotic skin microbiota that promotes skin inflammation. Cell Host Microbe. (2017) 22:13–24 e4. 10.1016/j.chom.2017.06.006
    1. Whiteside SA, Razvi H, Dave S, Reid G, Burton JP. The microbiome of the urinary tract–a role beyond infection. Nat Rev Urol. (2015) 12:81–90. 10.1038/nrurol.2014.361
    1. Rothschild D, Weissbrod O, Barkan E, Kurilshikov A, Korem T, Zeevi D, et al. . Environment dominates over host genetics in shaping human gut microbiota. Nature. (2018) 555:210–5. 10.1038/nature25973
    1. Borgo F, Garbossa S, Riva A, Severgnini M, Luigiano C, Benetti A, et al. . Body mass index and sex affect diverse microbial niches within the gut. Front Microbiol. (2018) 9:213. 10.3389/fmicb.2018.00213
    1. Goodrich JK, Davenport ER, Beaumont M, Jackson MA, Knight R, Ober C, et al. . Genetic determinants of the gut microbiome in UK twins. Cell Host Microbe. (2016) 19:731–43. 10.1016/j.chom.2016.04.017
    1. Faust K, Raes J. Host-microbe interaction: Rules of the game for microbiota. Nature. (2016) 534:182–3. 10.1038/534182a
    1. Mazmanian SK, Liu CH, Tzianabos AO, Kasper DL. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell. (2005) 122:107–18. 10.1016/j.cell.2005.05.007
    1. Chung H, Pamp SJ, Hill JA, Surana NK, Edelman SM, Troy EB, et al. . Gut immune maturation depends on colonization with a host-specific microbiota. Cell. (2012) 149:1578–93. 10.1016/j.cell.2012.04.037
    1. Bouskra D, Brezillon C, Berard M, Werts C, Varona R, Boneca IG, et al. . Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis. Nature. (2008) 456:507–10. 10.1038/nature07450
    1. Tremaroli V, Backhed F. Functional interactions between the gut microbiota and host metabolism. Nature. (2012) 489:242–9. 10.1038/nature11552
    1. Nicholson JK, Holmes E, Kinross J, Burcelin R, Gibson G, Jia W, et al. . Host-gut microbiota metabolic interactions. Science. (2012) 336:1262–7. 10.1126/science.1223813
    1. Piewngam P, Zheng Y, Nguyen TH, Dickey SW, Joo HS, Villaruz AE, et al. . Pathogen elimination by probiotic Bacillus via signalling interference. Nature. (2018) 562:532–7. 10.1038/s41586-018-0616-y
    1. Kim YG, Sakamoto K, Seo SU, Pickard JM, Gillilland MG, Pudlo NA, et al. . Neonatal acquisition of Clostridia species protects against colonization by bacterial pathogens. Science. (2017) 356:312–5. 10.1126/science.aag2029
    1. Sassone-Corsi M, Nuccio SP, Liu H, Hernandez D, Vu CT, Takahashi AA, et al. . Microcins mediate competition among Enterobacteriaceae in the inflamed gut. Nature. (2016) 540:280–283. 10.1038/nature20557
    1. Schuijt TJ, Lankelma JM, Scicluna BP, Melo FD, Roelofs TH, de Boer JD, et al. . The gut microbiota plays a protective role in the host defence against pneumococcal pneumonia. Gut. (2016) 65:575–83. 10.1136/gutjnl-2015-309728
    1. Karst SM, The influence of commensal bacteria on infection with enteric viruses. Nat Rev Microbiol. (2016) 14:197–204. 10.1038/nrmicro.2015.25
    1. Berger AK, Mainou BA. Interactions between enteric bacteria and eukaryotic viruses impact the outcome of infection. Viruses. (2018) 10:19. 10.3390/v10010019
    1. Pfeiffer JK, Virgin HW. Viral immunity. Transkingdom control of viral infection and immunity in the mammalian intestine. Science. (2016) 351:5872. 10.1126/science.aad5872
    1. Sullender ME, Baldridge MT. Norovirus interactions with the commensal microbiota. PLoS Pathog. (2018) 14:e1007183. 10.1371/journal.ppat.1007183
    1. Robinson CM, Pfeiffer JK. Viruses and the microbiota. Ann Rev Virol. (2014) 1:55–69. 10.1146/annurev-virology-031413-085550
    1. Erickson AK, Jesudhasan PR, Mayer MJ, Narbad A, Winter SE, Pfeiffer JK. Bacteria facilitate enteric virus co-infection of mammalian cells and promote genetic recombination. Cell Host Microbe. (2018) 23:77–88 e5. 10.1016/j.chom.2017.11.007
    1. Kuss SK, Best GT, Etheredge CA, Pruijssers AJ, Frierson JM, Hooper LV, et al. . Intestinal microbiota promote enteric virus replication and systemic pathogenesis. Science. (2011) 334:249–52. 10.1126/science.1211057
    1. Robinson CM, Jesudhasan PR, Pfeiffer JK. Bacterial lipopolysaccharide binding enhances virion stability and promotes environmental fitness of an enteric virus. Cell Host Microbe. (2014) 15:36–46. 10.1016/j.chom.2013.12.004
    1. Berger AK, Yi H, Kearns DB, Mainou BA. Bacteria and bacterial envelope components enhance mammalian reovirus thermostability. PLoS Pathog. (2017) 13:e1006768. 10.1371/journal.ppat.1006768
    1. Gorres KL, Daigle D, Mohanram S, Miller G. Activation and repression of Epstein-Barr Virus and Kaposi's sarcoma-associated herpesvirus lytic cycles by short- and medium-chain fatty acids. J Virol. (2014) 88:8028–44. 10.1128/JVI.00722-14
    1. Wilen CB, Lee S, Hsieh LL, Orchard RC, Desai C, Hykes BL, Jr, et al. . Tropism for tuft cells determines immune promotion of norovirus pathogenesis. Science. (2018) 360:204–8. 10.1126/science.aar3799
    1. von Moltke J, Ji M, Liang HE, Locksley RM. Tuft-cell-derived IL-25 regulates an intestinal ILC2-epithelial response circuit. Nature. (2016) 529:221–5. 10.1038/nature16161
    1. Jones MK, Watanabe M, Zhu S, Graves CL, Keyes LR, Grau KR, et al. . Enteric bacteria promote human and mouse norovirus infection of B cells. Science. (2014) 346:755–9. 10.1126/science.1257147
    1. Kane M, Case LK, Kopaskie K, Kozlova A, MacDearmid C, Chervonsky AV, et al. . Successful transmission of a retrovirus depends on the commensal microbiota. Science. (2011) 334:245–9. 10.1126/science.1210718
    1. Jude BA, Pobezinskaya Y, Bishop J, Parke S, Medzhitov RM, Chervonsky AV, et al. . Subversion of the innate immune system by a retrovirus. Nat Immunol. (2003) 4:573–8. 10.1038/ni926
    1. Wilks J, Lien E, Jacobson AN, Fischbach MA, Qureshi N, Chervonsky AV, et al. . Mammalian lipopolysaccharide receptors incorporated into the retroviral envelope augment virus transmission. Cell Host Microbe. (2015) 18:456–62. 10.1016/j.chom.2015.09.005
    1. Baldridge MT, Nice TJ, McCune BT, Yokoyama CC, Kambal A, Wheadon M, et al. . Commensal microbes and interferon-lambda determine persistence of enteric murine norovirus infection. Science. (2015) 347:266–9. 10.1126/science.1258025
    1. Uchiyama R, Chassaing B, Zhang BY, Gewirtz AT. Antibiotic treatment suppresses rotavirus infection and enhances specific humoral immunity. J Infect Dis. (2014) 210:171–82. 10.1093/infdis/jiu037
    1. Young GR, Eksmond U, Salcedo R, Alexopoulou L, Stoye JP, Kassiotis G. Resurrection of endogenous retroviruses in antibody-deficient mice. Nature. (2012) 491:774–48. 10.1038/nature11599
    1. Aguilera ER, Erickson AK, Jesudhasan PR, Robinson CM, Pfeiffer JK. Plaques formed by mutagenized viral populations have elevated coinfection frequencies. MBio. (2017) 8:16. 10.1128/mBio.02020-16
    1. Chen YH, Du W, Hagemeijer MC, Takvorian PM, Pau C, Cali A, et al. . Phosphatidylserine vesicles enable efficient en bloc transmission of enteroviruses. Cell. (2015) 160:619–30. 10.1016/j.cell.2015.01.032
    1. Combe M, Garijo R, Geller R, Cuevas JM, Sanjuan R. Single-cell analysis of RNA virus infection identifies multiple genetically diverse viral genomes within single infectious units. Cell Host Microbe. (2015) 18:424–32. 10.1016/j.chom.2015.09.009
    1. Ma SD, Hegde S, Young KH, Sullivan R, Rajesh D, Zhou Y, et al. . A new model of Epstein-Barr virus infection reveals an important role for early lytic viral protein expression in the development of lymphomas. J Virol. (2011) 85:165–77. 10.1128/JVI.01512-10
    1. Asai S, Nakamura Y, Yamamura M, Ikezawa H, Namikawa I. Quantitative analysis of the Epstein-Barr virus-inducing properties of short-chain fatty acids present in the culture fluids of oral bacteria. Arch Virol. (1991) 119:291–6. 10.1007/BF01310678
    1. Koh A, De Vadder F, Kovatcheva-Datchary P, Backhed F. From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell. (2016) 165:1332–45. 10.1016/j.cell.2016.05.041
    1. Sawicki CM, Livingston KA, Obin M, Roberts SB, Chung M, McKeown NM. Dietary fiber and the human gut microbiota: application of evidence mapping methodology. Nutrients. (2017) 9:125. 10.3390/nu9020125
    1. Lee S, Wilen CB, Orvedahl A, McCune BT, Kim KW, Orchard RC, et al. . Norovirus cell tropism is determined by combinatorial action of a viral non-structural protein and host cytokine. Cell Host Microbe. (2017) 22:449–59 e4. 10.1016/j.chom.2017.08.021
    1. Haga K, Fujimoto A, Takai-Todaka R, Miki M, Doan YH, Murakami K, et al. . Functional receptor molecules CD300lf and CD300ld within the CD300 family enable murine noroviruses to infect cells. Proc Natl Acad Sci USA. (2016) 113:E6248–55. 10.1073/pnas.1605575113
    1. Miura T, Sano D, Suenaga A, Yoshimura T, Fuzawa M, Nakagomi T, et al. . Histo-blood group antigen-like substances of human enteric bacteria as specific adsorbents for human noroviruses. J Virol. (2013) 87:9441–51. 10.1128/JVI.01060-13
    1. Tedesco D, Thapa M, Chin CY, Ge Y, Gong M, Li J, et al. . Alterations in intestinal microbiota lead to production of interleukin 17 by intrahepatic gammadelta T-cell receptor-positive cells and pathogenesis of cholestatic liver disease. Gastroenterology. (2018) 154:2178–93. 10.1053/j.gastro.2018.02.019
    1. Yu H, Gagliani N, Ishigame H, Huber S, Zhu S, Esplugues E, et al. . Intestinal type 1 regulatory T cells migrate to periphery to suppress diabetogenic T cells and prevent diabetes development. Proc Natl Acad Sci USA. (2017) 114:10443–8. 10.1073/pnas.1705599114
    1. Zhao Q, Elson CO. Adaptive immune education by gut microbiota antigens. Immunology. (2018) 154:28–37. 10.1111/imm.12896
    1. Sefik E, Geva-Zatorsky N, Oh S, Konnikova L, Zemmour D, McGuire AM, et al. . Individual intestinal symbionts induce a distinct population of RORgamma(+) regulatory T cells. Science. (2015) 349:993–7. 10.1126/science.aaa9420
    1. Jakobsson HE, Abrahamsson TR, Jenmalm MC, Harris K, Quince C, Jernberg C, et al. . Decreased gut microbiota diversity, delayed Bacteroidetes colonisation and reduced Th1 responses in infants delivered by caesarean section. Gut. (2014) 63:559–66. 10.1136/gutjnl-2012-303249
    1. Tanoue T, Atarashi K, Honda K. Development and maintenance of intestinal regulatory T cells. Nat Rev Immunol. (2016) 16:295–309. 10.1038/nri.2016.36
    1. Round JL, Mazmanian SK. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci USA. (2010) 107:12204–9. 10.1073/pnas.0909122107
    1. Basic M, Keubler LM, Buettner M, Achard M, Breves G, Schroder B, et al. . Norovirus triggered microbiota-driven mucosal inflammation in interleukin 10-deficient mice. Inflamm Bowel Dis. (2014) 20:431–43. 10.1097/01.MIB.0000441346.86827.ed
    1. Botic T, Klingberg TD, Weingartl H, Cencic A. A novel eukaryotic cell culture model to study antiviral activity of potential probiotic bacteria. Int J Food Microbiol. (2007) 115:227–34. 10.1016/j.ijfoodmicro.2006.10.044
    1. Wang ZY, Chai WD, Burwinkel M, Twardziok S, Wrede P, Palissa C, et al. . Inhibitory influence of Enterococcus faecium on the propagation of swine influenza A virus in vitro. PLoS ONE. (2013) 8:e53043. 10.1371/journal.pone.0053043
    1. Bandoro C, Runstadler JA. Bacterial lipopolysaccharide destabilizes influenza viruses. mSphere. (2017) 2:17. 10.1128/mSphere.00267-17
    1. Chen HW, Liu PF, Liu YT, Kuo S, Zhang XQ, Schooley RT, et al. . Nasal commensal Staphylococcus epidermidis counteracts influenza virus. Sci Rep. (2016) 6:27870. 10.1038/srep27870
    1. Tuyama CG, Cheshenko N, Carlucci MJ, Li JH, Li H, Goldberg CL, et al. . ACIDFORM inactivates herpes simplex virus and prevents genital herpes in a mouse model: optimal candidate for microbicide combinations. J Infect Dis. (2006) 194:795–803. 10.1086/506948
    1. Conti C, Malacrino C, Mastromarino P. Inhibition of herpes simplex virus type 2 by vaginal lactobacilli. J Physiol Pharmacol. (2009) 60:19–26.
    1. Mastromarino P, Cacciotti F, Masci A, Mosca L. Antiviral activity of Lactobacillus brevis towards herpes simplex virus type 2: Role of cell wall associated components. Anaerobe. (2011) 17:334–6. 10.1016/j.anaerobe.2011.04.022
    1. Steed AL, Christophi GP, Kaiko GE, Sun LL, Goodwin VM, Jain U, et al. . The microbial metabolite desaminotyrosine protects from influenza through type I interferon. Science. (2017) 357:498–502. 10.1126/science.aam5336
    1. Yitbarek A, Alkie T, Taha-Abdelaziz K, Astill J, Rodriguez-Lecompte JC, Parkinson J, et al. . Gut microbiota modulates type I interferon and antibody-mediated immune responses in chickens infected with influenza virus subtype H9N2. Benef Microbes. (2018) 9:417–27. 10.3920/BM2017.0088
    1. Hensley-McBain T, Zevin AS, Manuzak J, Smith E, Gile J, Miller C, et al. . Effects of fecal microbial transplantation on microbiome and immunity in simian immunodeficiency virus-infected macaques. J Virol. (2016) 90:4981–9. 10.1128/JVI.00099-16
    1. Abt MC, Osborne LC, Monticelli LA, Doering TA, Alenghat T, Sonnenberg GF, et al. . Commensal bacteria calibrate the activation threshold of innate antiviral immunity. Immunity. (2012) 37:158–70. 10.1016/j.immuni.2012.04.011
    1. Ichinohe T, Pang IK, Kumamoto Y, Peaper DR, Ho JH, Murray TS, et al. . Microbiota regulates immune defense against respiratory tract influenza A virus infection. Proc Natl Acad Sci USA. (2011) 108:5354–9. 10.1073/pnas.1019378108
    1. Oh JE, Kim BC, Chang DH, Kwon M, Lee SY, Kang D, et al. . Dysbiosis-induced IL-33 contributes to impaired antiviral immunity in the genital mucosa. Proc Natl Acad Sci USA. (2016) 113:E762–71. 10.1073/pnas.1518589113
    1. Gonzalez-Perez G, Lamouse-Smith ES, Gastrointestinal microbiome dysbiosis in infant mice alters peripheral CD8+ T cell receptor signaling. Front Immunol. (2017) 8:265. 10.3389/fimmu.2017.00265
    1. Wang Z, MacLeod DT, Di Nardo A. Commensal bacteria lipoteichoic acid increases skin mast cell antimicrobial activity against vaccinia viruses. J Immunol. (2012) 189:1551–8. 10.4049/jimmunol.1200471
    1. Gonzalez-Perez G, Hicks AL, Tekieli TM, Radens CM, Williams BL, Lamouse-Smith ES. Maternal antibiotic treatment impacts development of the neonatal intestinal microbiome and antiviral immunity. J Immunol. (2016) 196:3768–79. 10.4049/jimmunol.1502322
    1. Rosshart SP, Vassallo BG, Angeletti D, Hutchinson DS, Morgan AP, Takeda K, et al. . Wild mouse gut microbiota promotes host fitness and improves disease resistance. Cell. (2017) 171:1015–28 e13. 10.1016/j.cell.2017.09.016
    1. Grayson MH, Camarda LE, Hussain SA, Zemple SJ, Hayward M, Lam V, et al. . Intestinal microbiota disruption reduces regulatory T cells and increases respiratory viral infection mortality through increased IFNgamma production. Front Immunol. (2018) 9:1587. 10.3389/fimmu.2018.01587
    1. Chou HH, Chien WH, Wu LL, Cheng CH, Chung CH, Horng JH, et al. . Age-related immune clearance of hepatitis B virus infection requires the establishment of gut microbiota. Proc Natl Acad Sci USA. (2015) 112:2175–80. 10.1073/pnas.1424775112
    1. Fuglsang E, Pizzolla A, Krych L, Nielsen DS, Brooks AG, Frokiaer H, et al. Changes in gut microbiota prior to influenza A virus infection do not affect immune responses in pups or juvenile mice. Front Cell Infect Microbiol. (2018) 8:319 10.3389/fcimb.2018.00319
    1. Miedema F, Hazenberg MD, Tesselaar K, van Baarle D, de Boer RJ, Borghans JA. Immune activation and collateral damage in AIDS pathogenesis. Front Immunol. (2013) 4:298. 10.3389/fimmu.2013.00298
    1. Lu W, Feng Y, Jing F, Han Y, Lyu N, Liu F, et al. . Association between gut microbiota and CD4 recovery in HIV-1 infected patients. Front Microbiol. (2018) 9:1451. 10.3389/fmicb.2018.01451
    1. Paquin-Proulx D, Ching C, Vujkovic-Cvijin I, Fadrosh D, Loh L, Huang Y, et al. . Bacteroides are associated with GALT iNKT cell function and reduction of microbial translocation in HIV-1 infection. Mucosal Immunol. (2017) 10:69–78. 10.1038/mi.2016.34
    1. Stewart CJ, Mansbach JM, Ajami NJ, Petrosino JF, Zhu Z, Liang L, et al. . Serum metabolome is associated with nasopharyngeal microbiota and disease severity among infants with bronchiolitis. J Infect Dis. (2019) 219:2005–14. 10.1093/infdis/jiz021
    1. de Steenhuijsen Piters WA, Heinonen S, Hasrat R, Bunsow E, Smith B, Suarez-Arrabal MC, et al. . Nasopharyngeal microbiota, host transcriptome, and disease severity in children with respiratory syncytial virus infection. Am J Res Critic Care Med. (2016) 194:1104–15. 10.1164/rccm.201602-0220OC
    1. Terrault NA, Bzowej NH, Chang KM, Hwang JP, Jonas MM, Murad MH, et al. . AASLD guidelines for treatment of chronic hepatitis B. Hepatology. (2016) 63:261–83. 10.1002/hep.28156
    1. Ren YD, Ye ZS, Yang LZ, Jin LX, Wei WJ, Deng YY, et al. . Fecal microbiota transplantation induces hepatitis B virus e-antigen (HBeAg) clearance in patients with positive HBeAg after long-term antiviral therapy. Hepatology. (2017) 65:1765–8. 10.1002/hep.29008
    1. Haak BW, Littmann ER, Chaubard JL, Pickard AJ, Fontana E, Adhi F, et al. . Impact of gut colonization with butyrate-producing microbiota on respiratory viral infection following allo-HCT. Blood. (2018) 131:2978–86. 10.1182/blood-2018-01-828996
    1. Gopinath S, Kim MV, Rakib T, Wong PW, van Zandt M, Barry NA, et al. . Topical application of aminoglycoside antibiotics enhances host resistance to viral infections in a microbiota-independent manner. Nat Microbiol. (2018) 3:611–21. 10.1038/s41564-018-0138-2
    1. Zhu S, Jones MK, Hickman D, Han S, Reeves W, Karst SM. Norovirus antagonism of B-cell antigen presentation results in impaired control of acute infection. Mucosal Immunol. (2016) 9:1559–70. 10.1038/mi.2016.15
    1. Wilks J, Beilinson H, Theriault B, Chervonsky A, Golovkina T. Antibody-mediated immune control of a retrovirus does not require the microbiota. J Virol. (2014) 88:6524–7. 10.1128/JVI.00251-14
    1. Isaak DD, Bartizal KF, Caulfield MJ. Decreased pathogenicity of murine leukemia virus-Moloney in gnotobiotic mice. Leukemia. (1988) 2:540–4.
    1. Kouttab NM, Jutila JW. Friend leukemia virus infection in germfree mice following antigen stimulation. J Immunol. (1972) 108:591–5.
    1. Mirand EA, Grace JT, Jr. Responses of germ-free mice to friend virus. Nature. (1963) 200:92–3. 10.1038/200092a0
    1. Ammann CG, Messer RJ, Peterson KE, Hasenkrug KJ. Lactate dehydrogenase-elevating virus induces systemic lymphocyte activation via TLR7-dependent IFNalpha responses by plasmacytoid dendritic cells. PLoS ONE. (2009) 4:e6105. 10.1371/journal.pone.0006105
    1. Wilks J, Golovkina T. Influence of microbiota on viral infections. PLoS Pathog. (2012) 8:e1002681. 10.1371/journal.ppat.1002681
    1. Kumar A, Vlasova AN, Deblais L, Huang HC, Wijeratne A, Kandasamy S, et al. . Impact of nutrition and rotavirus infection on the infant gut microbiota in a humanized pig model. BMC Gastroenterol. (2018) 18:93. 10.1186/s12876-018-0810-2
    1. Jang JY, Kim S, Kwon MS, Lee J, Yu DH, Song RH, et al. . Rotavirus-mediated alteration of gut microbiota and its correlation with physiological characteristics in neonatal calves. J Microbiol. (2018) 57:113–21. 10.1007/s12275-019-8549-1
    1. Ma X, Wang Q, Li H, Xu C, Cui N, Zhao X. 16S rRNA genes Illumina sequencing revealed differential cecal microbiome in specific pathogen free chickens infected with different subgroup of avian leukosis viruses. Vet Microbiol. (2017) 207:195–204. 10.1016/j.vetmic.2017.05.016
    1. Zhao N, Li M, Luo J, Wang S, Liu S, Wang S, et al. . Impacts of canine distemper virus infection on the giant panda population from the perspective of gut microbiota. Sci Rep. (2017) 7:39954. 10.1038/srep39954
    1. Ding ZF, Cao MJ, Zhu XS, Xu GH, Wang RL. Changes in the gut microbiome of the Chinese mitten crab (Eriocheir sinensis) in response to White spot syndrome virus (WSSV) infection. J Fish Dis. (2017) 40:1561–71. 10.1111/jfd.12624
    1. Li Y, Saxena D, Chen Z, Liu G, Abrams WR, Phelan JA, et al. . HIV infection and microbial diversity in saliva. J Clin Microbiol. (2014) 52:1400–11. 10.1128/JCM.02954-13
    1. Dang AT, Cotton S, Sankaran-Walters S, Li CS, Lee CY, Dandekar S, et al. . Evidence of an increased pathogenic footprint in the lingual microbiome of untreated HIV infected patients. BMC Microbiol. (2012) 12:153. 10.1186/1471-2180-12-153
    1. Mukherjee PK, Chandra J, Retuerto M, Sikaroodi M, Brown RE, Jurevic R, et al. . Oral mycobiome analysis of HIV-infected patients: identification of Pichia as an antagonist of opportunistic fungi. PLoS Pathog. (2014) 10:e1003996. 10.1371/journal.ppat.1003996
    1. Cribbs SK, Uppal K, Li S, Jones DP, Huang L, Tipton L, et al. . Correlation of the lung microbiota with metabolic profiles in bronchoalveolar lavage fluid in HIV infection. Microbiome. (2016) 4:3. 10.1186/s40168-016-0147-4
    1. Moeller AH, Shilts M, Li Y, Rudicell RS, Lonsdorf EV, Pusey AE, et al. . SIV-induced instability of the chimpanzee gut microbiome. Cell Host Microbe. (2013) 14:340–5. 10.1016/j.chom.2013.08.005
    1. Degnan PH, Pusey AE, Lonsdorf EV, Goodall J, Wroblewski EE, Wilson ML, et al. . Factors associated with the diversification of the gut microbial communities within chimpanzees from Gombe National Park. Proc Natl Acad Sci USA. (2012) 109:13034–9. 10.1073/pnas.1110994109
    1. Noguera-Julian M, Rocafort M, Guillen Y, Rivera J, Casadella M, Nowak P, et al. . Gut microbiota linked to sexual preference and HIV infection. EBioMed. (2016) 5:135–46. 10.1016/j.ebiom.2016.01.032
    1. Vujkovic-Cvijin I, Dunham RM, Iwai S, Maher MC, Albright RG, Broadhurst MJ, et al. . Dysbiosis of the gut microbiota is associated with HIV disease progression and tryptophan catabolism. Sci Transl Med. (2013) 5:193ra91. 10.1126/scitranslmed.3006438
    1. Sun Y, Ma Y, Lin P, Tang YW, Yang L, Shen Y, et al. . Fecal bacterial microbiome diversity in chronic HIV-infected patients in China. Emerg Microbes Infect. (2016) 5:e31. 10.1038/emi.2016.25
    1. Ji Y, Zhang F, Zhang R, Shen Y, Liu L, Wang J, et al. . Changes in intestinal microbiota in HIV-1-infected subjects following cART initiation: influence of CD4+ T cell count. Emerg Microbes Infect. (2018) 7:113. 10.1038/s41426-018-0117-y
    1. Serrano-Villar S, Rojo D, Martinez-Martinez M, Deusch S, Vazquez-Castellanos JF, Sainz T, et al. . HIV infection results in metabolic alterations in the gut microbiota different from those induced by other diseases. Sci Rep. (2016) 6:26192. 10.1038/srep26192
    1. Mayuzumi H, Inagaki-Ohara K, Uyttenhove C, Okamoto Y, Matsuzaki G. Interleukin-17A is required to suppress invasion of Salmonella enterica serovar Typhimurium to enteric mucosa. Immunology. (2010) 131:377–85. 10.1111/j.1365-2567.2010.03310.x
    1. Raffatellu M, Santos RL, Verhoeven DE, George MD, Wilson RP, Winter SE, et al. . Simian immunodeficiency virus-induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut. Nat Med. (2008) 14:421–8. 10.1038/nm1743
    1. Manfredi R, Chiodo F. Salmonella typhi disease in HIV-infected patients: case reports and literature review. Infez Med. (1999) 7:49–53.
    1. Haas A, Zimmermann K, Graw F, Slack E, Rusert P, Ledergerber B, et al. . Systemic antibody responses to gut commensal bacteria during chronic HIV-1 infection. Gut. (2011) 60:1506–19. 10.1136/gut.2010.224774
    1. Edouard S, Million M, Bachar D, Dubourg G, Michelle C, Ninove L, et al. . The nasopharyngeal microbiota in patients with viral respiratory tract infections is enriched in bacterial pathogens. Eur J Clin Microbiol Infect Dis. (2018) 37:1725–33. 10.1007/s10096-018-3305-8
    1. Li Y, Ding J, Xiao Y, Xu B, He W, Yang Y, et al. 16S rDNA sequencing analysis of upper respiratory tract flora in patients with influenza H1N1 virus infection. Front Lab Med. (2017) 1:16–26. 10.1016/j.flm.2017.02.005
    1. Wen Z, Xie G, Zhou Q, Qiu C, Li J, Hu Q, et al. . Distinct nasopharyngeal and oropharyngeal microbiota of children with influenza a virus compared with healthy children. BioMed Res Intl. (2018) 2018:6362716. 10.1155/2018/6362716
    1. Borges L, Giongo A, Pereira LM, Trindade FJ, Gregianini TS, Campos FS, et al. . Comparison of the nasopharynx microbiome between influenza and non-influenza cases of severe acute respiratory infections: a pilot study. Health Science Rep. (2018) 1:e47. 10.1002/hsr2.47
    1. Ramos-Sevillano E, Wade WG, Mann A, Gilbert A, Lambkin-Williams R, Killingley B, et al. . The effect of influenza virus on the human oropharyngeal microbiome. Clin Infect Dis. (2019) 68:1993–2002. 10.1093/cid/ciy821
    1. Yildiz S, Mazel-Sanchez B, Kandasamy M, Manicassamy B, Schmolke M. Influenza A virus infection impacts systemic microbiota dynamics and causes quantitative enteric dysbiosis. Microbiome. (2018) 6:9. 10.1186/s40168-017-0386-z
    1. Groves HT, Cuthbertson L, James P, Moffatt MF, Cox MJ, Tregoning JS. Respiratory disease following viral lung infection alters the murine gut microbiota. Front Immunol. (2018) 9:182. 10.3389/fimmu.2018.00182
    1. Zhao N, Wang SP, Li HY, Liu SL, Li M, Luo J, et al. . Influence of novel highly pathogenic avian influenza A(H5N1) virus infection on migrating whooper swans fecal microbiota. Front Cell Infect Microbiol. (2018) 8:46. 10.3389/fcimb.2018.00046
    1. Wang J, Li FQ, Wei HM, Lian ZX, Sun R, Tian ZG. Respiratory influenza virus infection induces intestinal immune injury via microbiota-mediated Th17 cell-dependent inflammation. J Exp Med. (2014) 211:2397–410. 10.1084/jem.20140625
    1. Yitbarek A, Weese JS, Alkie TN, Parkinson J, Sharif S. Influenza A virus subtype H9N2 infection disrupts the composition of intestinal microbiota of chickens. Fems Microbiol Ecol. (2018) 94:165. 10.1093/femsec/fix165
    1. Deriu E, Boxx GM, He XS, Pan C, Benavidez SD, Cen LJ, et al. . Influenza virus affects intestinal microbiota and secondary salmonella infection in the gut through type I interferons. Plos Pathog. (2016) 12:e1005572. 10.1371/journal.ppat.1005572
    1. Wang J, Wang Y, Zhang X, Liu J, Zhang Q, Zhao Y, et al. . Gut microbial dysbiosis is associated with altered hepatic functions and serum metabolites in chronic hepatitis B patients. Front Microbiol. (2017) 8:2222. 10.3389/fmicb.2017.02222
    1. Xu M, Wang B, Fu Y, Chen Y, Yang F, Lu H, et al. . Changes of fecal Bifidobacterium species in adult patients with hepatitis B virus-induced chronic liver disease. Microb Ecol. (2012) 63:304–13. 10.1007/s00248-011-9925-5
    1. Inoue T, Nakayama J, Moriya K, Kawaratani H, Momoda R, Ito K, et al. . Gut dysbiosis associated with hepatitis C virus infection. Clin Infect Dis. (2018) 67:869–77. 10.1093/cid/ciy205
    1. Aly AM, Adel A, El-Gendy AO, Essam TM, Aziz RK. Gut microbiome alterations in patients with stage 4 hepatitis C. Gut Pathog. (2016) 8:42. 10.1186/s13099-016-0124-2
    1. Chen Y, Chen ZJ, Guo RY, Chen N, Lu HF, Huang SA, et al. . Correlation between gastrointestinal fungi and varying degrees of chronic hepatitis B virus infection. Diagn Micr Infec Dis. (2011) 70:492–8. 10.1016/j.diagmicrobio.2010.04.005
    1. Heidrich B, Vital M, Plumeier I, Doscher N, Kahl S, Kirschner J, et al. . Intestinal microbiota in patients with chronic hepatitis C with and without cirrhosis compared with healthy controls. Liver Int. (2018) 38:50–8. 10.1111/liv.13485
    1. Lu H, Wu Z, Xu W, Yang J, Chen Y, Li L. Intestinal microbiota was assessed in cirrhotic patients with hepatitis B virus infection. Intestinal microbiota of HBV cirrhotic patients. Microb Ecol. (2011) 61:693–703. 10.1007/s00248-010-9801-8
    1. Ling Z, Liu X, Cheng Y, Jiang X, Jiang H, Wang Y, et al. . decreased diversity of the oral microbiota of patients with hepatitis B virus-induced chronic liver disease: a pilot project. Sci Rep. (2015) 5:17098. 10.1038/srep17098
    1. Zhao Y, Mao YF, Tang YS, Ni MZ, Liu QH, Wang Y, et al. . Altered oral microbiota in chronic hepatitis B patients with different tongue coatings. World J Gastroenterol. (2018) 24:3448–61. 10.3748/wjg.v24.i30.3448
    1. Nelson AM, Walk ST, Taube S, Taniuchi M, Houpt ER, Wobus CE, et al. . Disruption of the human gut microbiota following Norovirus infection. PLoS ONE. (2012) 7:e48224. 10.1371/journal.pone.0048224
    1. Almand EA, Moore MD, Outlaw J, Jaykus LA. Human norovirus binding to select bacteria representative of the human gut microbiota. PLoS ONE. (2017) 12:e0173124. 10.1371/journal.pone.0173124
    1. Kernbauer E, Ding Y, Cadwell K. An enteric virus can replace the beneficial function of commensal bacteria. Nature. (2014) 516:94–8. 10.1038/nature13960
    1. Martin CR, Osadchiy V, Kalani A, Mayer EA. The brain-gut-microbiome axis. Cell Mol Gastroenterol Hepatol. (2018) 6:133–48. 10.1016/j.jcmgh.2018.04.003
    1. O'Mahony SM, Clarke G, Borre YE, Dinan TG, Cryan JF. Serotonin, tryptophan metabolism and the brain-gut-microbiome axis. Behav Brain Res. (2015) 277:32–48. 10.1016/j.bbr.2014.07.027
    1. Dinan TG, Cryan JF. Gut instincts: microbiota as a key regulator of brain development, ageing and neurodegeneration. J Physiol. (2017) 595:489–503. 10.1113/JP273106
    1. de Lartigue G, de La Serre CB, Raybould HE. Vagal afferent neurons in high fat diet-induced obesity; intestinal microflora, gut inflammation and cholecystokinin. Physiol Behav. (2011) 105:100–5. 10.1016/j.physbeh.2011.02.040
    1. Park AJ, Collins J, Blennerhassett PA, Ghia JE, Verdu EF, Bercik P, et al. . Altered colonic function and microbiota profile in a mouse model of chronic depression. Neurogastroent Motil. (2013) 25:733–E575. 10.1111/nmo.12153
    1. Pulikkan J, Mazumder A, Grace T. Role of the gut microbiome in autism spectrum disorders. Adv Exp Med Biol. (2019) 1118:253–69. 10.1007/978-3-030-05542-4_13
    1. Berer K, Mues M, Koutrolos M, Rasbi ZA, Boziki M, Johner C, et al. . Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature. (2011) 479:538–41. 10.1038/nature10554
    1. Mohajeri MH, La Fata G, Steinert RE, Weber P. Relationship between the gut microbiome and brain function. Nutr Rev. (2018) 76:481–96. 10.1093/nutrit/nuy009
    1. Osadchiy V, Martin CR, Mayer EA. The gut-brain axis and the microbiome: mechanisms and clinical implications. Clin Gastroenterol. (2019) 17:322–32. 10.1016/j.cgh.2018.10.002
    1. Carrillo-Salinas FJ, Mestre L, Mecha M, Feliu A, Del Campo R, Villarrubia N, et al. . Gut dysbiosis and neuroimmune responses to brain infection with Theiler's murine encephalomyelitis virus. Sci Rep. (2017) 7:44377. 10.1038/srep44377
    1. O'Toole PW, Marchesi JR, Hill C. Next-generation probiotics: the spectrum from probiotics to live biotherapeutics. Nat Microbiol. (2017) 2:17057. 10.1038/nmicrobiol.2017.57
    1. Zuo T, Wong SH, Lam K, Lui R, Cheung K, Tang W, et al. . Bacteriophage transfer during faecal microbiota transplantation in Clostridium difficile infection is associated with treatment outcome. Gut. (2018) 67:634–43. 10.1136/gutjnl-2017-313952
    1. Suez J, Zmora N, Zilberman-Schapira G, Mor U, Dori-Bachash M, Bashiardes S, et al. . Post-antibiotic gut mucosal microbiome reconstitution is impaired by probiotics and improved by autologous FMT. Cell. (2018) 174:1406–23 e16. 10.1016/j.cell.2018.08.047
    1. Zmora N, Zilberman-Schapira G, Suez J, Mor U, Dori-Bachash M, Bashiardes S, et al. . Personalized gut mucosal colonization resistance to empiric probiotics is associated with unique host and microbiome features. Cell. (2018) 174:1388–405 e21. 10.1016/j.cell.2018.08.041
    1. Limon JJ, Skalski JH, Underhill DM. Commensal fungi in health and disease. Cell Host Microbe. (2017) 22:156–65. 10.1016/j.chom.2017.07.002
    1. Barnett KC, Coronas-Serna JM, Zhou W, Ernandes MJ, Cao A, Kranzusch PJ, et al. Phosphoinositide interactions position cGAS at the plasma membrane to ensure efficient distinction between self- and viral DNA cell. (2019) 176:1432–1446.e11. 10.1016/j.cell.2019.01.049
    1. Lian H, Wei J, Zang R, Ye W, Yang Q, Zhang XN, et al. . ZCCHC3 is a co-sensor of cGAS for dsDNA recognition in innate immune response. Nat Commun. (2018) 9:3349. 10.1038/s41467-018-05559-w
    1. Seo GJ, Kim C, Shin WJ, Sklan EH, Eoh H, Jung JU. TRIM56-mediated monoubiquitination of cGAS for cytosolic DNA sensing. Nat Commun. (2018) 9:613. 10.1038/s41467-018-02936-3
    1. Schoggins JW, MacDuff DA, Imanaka N, Gainey MD, Shrestha B, Eitson JL, et al. . Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity. Nature. (2014) 505:691–5. 10.1038/nature12862
    1. Mann EA, Harmel-Laws E, Cohen MB, Steinbrecher KA. Guanylate cyclase C limits systemic dissemination of a murine enteric pathogen. BMC Gastroenterol. (2013) 13:135. 10.1186/1471-230X-13-135

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren